The Future is Now – Welcome to the Age of Injectables
WASHINGTON, DC, August 29, 2022 /24-7PressRelease/ — The ADAP Advocacy Association today shared its new comprehensive patient advocacy report, HIV LONG-ACTING AGENTS: Policy Considerations for Injectable Therapies under the Ryan White HIV/AIDS Program & State AIDS Drug Assistance Programs. This document provides a checklist of the main concepts requiring robust policy and programmatic conversations with people living with HIV/AIDS, as well as all the other local stakeholders within the local service delivery system regarding injectables.
The patient advocacy report, as well as its executive summary are available online at http://adapadvocacy.org/publications.html#ip.
Joey Wynn, Chair of the ADAP Injectables Advisory Committee, summarized: “We hope our report assists you, in your local community, in addressing the issues and complex topics to remove barriers to accessing care and treatment. It may also act as an informative tool for your ongoing advocacy at the local level, as well as your state, regional, and national perspectives.”
The ADAP Injectables Advisory Committee included Michelle Anderson with the Afiya Center, Tori Cooper with the Human Rights Campaign Foundation, Donna Sabatino with The AIDS Institute, Jennifer Eliasi MS, RD, CDN with Theratechnologies, Marcus Hopkins with Appalachian Learning Initiative, Jen Laws with the Community Access National Network (CANN), Warren Alexander O’Meara-Dates with The 6:52 Project Foundation, Dawn Patillo-Exum with Merck, Glen Pietrandoni, R.Ph with Avita Pharmacy, Cindy Snyder with ViiV Healthcare, Alex Vance with the International Association of Providers of AIDS Care (IAPAC), Marcus Wilson with Janssen Pharmaceutical Companies of Johnson & Johnson, and Joey Wynn with the Florida HIV/AIDS Advocacy Network (FHAAN).
To learn more about the ADAP Advocacy Association, AIDS Drug Assistance Programs, or HIV Long-Acting Agents, please email [email protected].
About the ADAP Advocacy Association: The ADAP Advocacy Association mission is to promote and enhance the AIDS Drug Assistance Programs (ADAPs) and improves access to care for persons living with HIV/AIDS. aaa+® works with advocates, community, health care, government, patients, pharmaceutical companies and other stakeholders to raise awareness, offer patient educational programs, and foster greater community collaboration.
For the original version of this press release, please visit 24-7PressRelease.com here